Maintaining oral health is crucial for overall well-being, yet many individuals overlook the importance of proper dental care ...

Scheduled for 13 weeks, the trial will assess the therapy’s safety, tolerability, and efficacy in weight loss.

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...

Acquisition expands high-value medical platform WESTLAKE, OHIO / ACCESSWIRE / January 7, 2025 / GEON ®Performance Solutions, ...

Introduction: Ethylhexylglycerin, identified by the CAS number 70445-33-9, is a multifunctional cosmetic ingredient and preservative booster that has found extensive use in the personal care and ...

Dibutyl Maleate (DBM), recognized by the CAS number 105-76-0, is a chemical compound with diverse applications across various industries. As an ester of maleic acid, DBM serves different purposes in ...

KANSAS CITY — Artificial Intelligence (AI) is playing an increasingly important role in product development, with applications ranging from optimizing formulations to improving food production ...

a digital platform that brings together over 120 years of Dow's polyurethane formulations. "Predictive Intelligence is a virtual lab, powered by a unified global data platform for artificial ...

JSKN033-102 is an open-label, multicenter, Phase Ⅰ/Ⅱ clinical study designed to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics and anti-tumor activity of JSKN033 in patients with ...

Since its establishment over 30 years ago, the World Trade Organization has played a central role in the multilateral trading ...

H.E. Abou-Zeid was an international development lead expert who has been serving Africa in various leading positions for over 30 years, mainly in international organizations: AFDB, UNDP and USAID.

Silexion is collaborating with Evonik on the development of a long-acting siRNA PLGA microparticle formulation, which has demonstrated high efficacy in preclinical models for KRAS-mutated cancers ...